Results 121 to 130 of about 31,699 (207)

Comparative analysis of cefoperazone-sulbactam and piperacillin-tazobactam in empirical treatment of acute biliary tract infections: a multicenter, retrospective, real-world study. [PDF]

Sci Rep
Yang L, Song Z, Chen D, Zhou N, Zhang P, Cao L.   +5 more
europepmc   +1 more source

Serum bactericidal activity of ampicillin and mezlocillin with and without sulbactam

, 1984
Two groups of five volunteers received the following regimens on three consecutive days: group 1: ampicilllin 3 g, sulbactam 1 g, ampicillin 3 g + sulbactam 1 g; group 2: mezlocillin 3 g, sulbactam 1 g, mezlocillin 3 g + sulbactam 1 g.
Klastersky, Jean, Van Der Auwera, Philippe   +1 more
core  

A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-Durlobactam. [PDF]

Clin Infect Dis
Sharara SL, Diaz L, Asempa TE, Martinez JRW, Canales N, Bergman Y, Murphy SG, Karaba SM, Clark AE, Zurawski DV, Cosgrove SE, Simner PJ, Munita JM, Tamma PD.   +13 more
europepmc   +1 more source

Indian Society of Critical Care Medicine Guidelines on Evidence-based Recommendations for the Treatment of Carbapenem-resistant Enterobacterales, Carbapenem-resistant <i>Acinetobacter baumannii</i>, and Carbapenem-resistant <i>Pseudomonas aeruginosa</i> in Critically Ill Patients: A GRADE-guided Approach. [PDF]

Indian J Crit Care Med
Todi SK, Jagiasi BG, Juneja D, Gopaldas JA, Soni KD, Karanth S, Singh R, Kharbanda M, Bhardwaj A, Sahoo TK, Bhosale S, Sinha S, Bharti M, Clerk AM, Kumar A, Rochwerg B, Singh VK, Bhattacharya PK.   +17 more
europepmc   +1 more source

Sulbactam Concentration in Critically Ill Patients with Hospital-Acquired Pneumonia: A Comparisons Stratified by Normal and Augmented Renal Clearance

Infection and Drug Resistance
Lin Zhang,1 Juan Zeng,1 Wenying Zhu,1 Jing Sha,1 Yue Tang,1 Bing Leng,2 Nan Guo,2 Jinjiao Jiang1 1Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People’s Republic of China ...
Zhang L, Zeng J, Zhu W, Sha J, Tang Y, Leng B, Guo N, Jiang J   +7 more
doaj  

REPRODUCTION STUDIES WITH SULBACTAM AND COMBINATIONS OF SULBACTAM AND CEFOPERAZONE IN RATS

CHEMOTHERAPY, 1984
HORIMOTO, MASAO, SAKAI, TAKEO, OHTSUKI, ISAO, NOGUCHI, YASUHIRO   +3 more
openaire   +1 more source

When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections? [PDF]

JAC Antimicrob Resist
Assimakopoulos SF, Ioannou S, Rodriguez-Bano J, Marangos M, Daikos GL.   +4 more
europepmc   +1 more source

Sulbactam Sodium [PDF]

, 2020
openaire   +1 more source

Consistent <i>in vitro</i> activity of sulbactam-durlobactam against genetically diverse carbapenem-resistant <i>Acinetobacter baumannii</i> in a high-endemic Brazilian setting. [PDF]

Antimicrob Agents Chemother
Collar GS, Dornelles LS, Salvador JC, Pinto JB, Pereira DC, Barth PO, Cardoso JVB, Matos WL, Mott MP, Barth AL, Martins AF, Caierão J.   +11 more
europepmc   +1 more source

Extreme and rapidly reversible prolongation of prothrombin time during cefoperazone/sulbactam therapy in a patient with gastrointestinal dysfunction and parenteral nutrition: a case report. [PDF]

Front Pharmacol
Gao TR, Zhu GW, Zhang QH, Gao ZP.
europepmc   +1 more source